Perioperative Optimization of the IBD Patient: How Many Biologics is Too Many?

Sunday, May 11, 2025

12:30 PM – 1:20 PM PT

Location: Ballroom 6C-F, Upper Level

Co-Moderator(s)

Kinga Olortegui, MD, MS, FACS

Assistant Professor
UChicago Medicine
Chicago, IL, United States

All of the relevant financial relationships listed below have been mitigated.
This individual has no financial relationships with ineligible companies.

Learning Objectives:

Upon completion of this activity, participants should be able to:

Optimize new IBD medications in the perioperative setting.
Identify challenges in unique IBD patient populations.
Utilize technology for improved diagnosis in the treatment of IBD.

CME Credit: 0.75
Self-Assessment Credit: 0.75
Contact Hours: 0.75

Inflammatory Bowel Disease is a complex chronic disease requiring a multidisciplinary approach to care. Despite advances in medical management, many patients will eventually need operative intervention. This symposium will discuss different aspects of medical management and perioperative optimization of the IBD patient.

Presentations:

12:30 PM – 12:35 PM PT

Introduction
Co-Moderator: Kinga S. Olortegui, MD, MS, FACS – UChicago Medicine
12:35 PM – 12:43 PM PT

IBD Management in Unique Patient Populations
Faculty: Sanjay Mohanty, MD (he/him/his) – Indiana University School of Medicine
12:43 PM – 12:51 PM PT

New IBD Medications and their Use in the Perioperative Setting
Faculty: Sushila Dalal, MD (she/her/hers) – University of Chicago Medicine
12:51 PM – 12:59 PM PT

Management of IBD Medications in the Perioperative Setting
Faculty: Lisa Marie Cannon, MD – University of Rochester Medical Center
12:59 PM – 1:07 PM PT

How Medication Effects Interoperative Decisions
Faculty: Athur Harikrishnan, MBBS, MS, MPhil, FRCS – Sheffield Teaching Hospitals, Sheffield, UK
1:08 PM – 1:20 PM PT

Question and Answer with Polling